Nezar Mohammed Boreak, Mazen Ahmed Qadi, Faisal Hadi Khormi, Luay Mutaen Faqiri, Sadeem Omar Zaylai, Yaser Ali Jad, Bassam Ali Hamdi, Asayil Juraybi
Journal: The journal of contemporary dental practice 2024;24(8):610-619
PMID: 38193186
AIM
This review aimed to evaluate the studies done with regard to the cytotoxicity associated with mineral trioxide aggregate (MTA)-based root canal sealers.
BACKGROUND
Root canal sealers are used during endodontic treatment as fillers to seal the gaps between the canal gutta-percha cone and canal walls. It is necessary to understand the cytotoxicity of these materials on human-derived cells as these materials interact with human cells periapically.
REVIEW RESULTS
Six studies were chosen for review. In these selected studies, along with MTA-based root canal sealers, other sealers were tested for cytotoxicity on human periodontal ligament (PDL) stem cells, human PDL fibroblasts, and human osteoblast cells. Regarding cytotoxicity, the studies were diverse, and most were based on 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl-2H-tetrazolium bromide) (MTT) assay. In general, the studies suggested that root canal sealers cause mild to severe cytotoxic effects and that several factors influence this effect, such as material setting time, concentration, and duration of exposure.
CONCLUSION
All studies in the review indicated that MTA. Fillapex must be used cautiously as it exhibited the highest cytotoxic effect compared to other MTA-based and non-MTA-based sealers.
CLINICAL SIGNIFICANCE
Endodontic sealers do serve the purpose of bridging the gaps between the gutta-percha cone and the canal wall but knowing its biocompatibility becomes important as the material is extruded beyond the apical foramen where it comes in contact with the surrounding tissues. The effect of sealers on the surrounding tissues affects the healing and prognosis of the treatment.
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.